LEMD3
Basic information
Region (hg38): 12:65169583-65248355
Links
Phenotypes
GenCC
Source:
- Buschke-Ollendorff syndrome (Definitive), mode of inheritance: AD
- melorheostosis (Definitive), mode of inheritance: AD
- Buschke-Ollendorff syndrome (Strong), mode of inheritance: AD
- melorheostosis with osteopoikilosis (Supportive), mode of inheritance: AD
- Buschke-Ollendorff syndrome (Supportive), mode of inheritance: AD
- isolated osteopoikilosis (Supportive), mode of inheritance: AD
- Buschke-Ollendorff syndrome (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Buschke-Ollendorff syndrome | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Dermatologic; Musculoskeletal | 12749062; 15489854; 17223882; 17087626; 19438932; 20618940; 20732851; 21985280 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (24 variants)
- Dermatofibrosis lenticularis disseminata (3 variants)
- Melorheostosis with osteopoikilosis (2 variants)
- LEMD3-related disorder (1 variants)
- Dermatofibrosis lenticularis disseminata, isolated (1 variants)
- Cerebral arteriovenous malformation (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LEMD3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 127 | 139 | ||||
missense | 290 | 11 | 305 | |||
nonsense | 14 | 19 | ||||
start loss | 1 | |||||
frameshift | 12 | 16 | ||||
inframe indel | 9 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
splice region | 1 | 3 | 6 | 2 | 12 | |
non coding | 23 | 31 | 30 | 84 | ||
Total | 28 | 12 | 328 | 170 | 39 |
Variants in LEMD3
This is a list of pathogenic ClinVar variants found in the LEMD3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-65169591-G-A | Dermatofibrosis lenticularis disseminata | Uncertain significance (Jan 13, 2018) | ||
12-65169598-T-C | Uncertain significance (Nov 17, 2023) | |||
12-65169598-T-TGGC | Uncertain significance (Jun 25, 2023) | |||
12-65169602-G-A | Likely benign (Jan 30, 2023) | |||
12-65169604-C-T | Uncertain significance (May 10, 2022) | |||
12-65169605-G-A | Likely benign (Nov 30, 2022) | |||
12-65169607-C-G | Uncertain significance (Aug 17, 2023) | |||
12-65169609-G-A | Inborn genetic diseases | Uncertain significance (Feb 28, 2024) | ||
12-65169609-G-C | Uncertain significance (Feb 09, 2022) | |||
12-65169611-A-C | Likely benign (Oct 18, 2023) | |||
12-65169611-A-G | Likely benign (Oct 24, 2022) | |||
12-65169612-G-A | Uncertain significance (Sep 08, 2023) | |||
12-65169613-C-T | Uncertain significance (Mar 08, 2023) | |||
12-65169616-C-T | Uncertain significance (Apr 06, 2021) | |||
12-65169618-G-A | Uncertain significance (Aug 24, 2023) | |||
12-65169622-C-T | Uncertain significance (Aug 10, 2023) | |||
12-65169624-C-T | Dermatofibrosis lenticularis disseminata | Uncertain significance (Nov 30, 2018) | ||
12-65169625-A-C | Uncertain significance (Mar 03, 2023) | |||
12-65169625-A-T | Dermatofibrosis lenticularis disseminata | Uncertain significance (Jan 12, 2018) | ||
12-65169635-G-A | Dermatofibrosis lenticularis disseminata | Likely benign (Dec 09, 2023) | ||
12-65169641-G-A | Likely benign (Jun 20, 2023) | |||
12-65169645-C-T | Inborn genetic diseases | Uncertain significance (Jun 23, 2023) | ||
12-65169650-C-G | Uncertain significance (Nov 01, 2022) | |||
12-65169652-C-T | Uncertain significance (Jul 16, 2023) | |||
12-65169660-CG-GC | Uncertain significance (Jun 04, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LEMD3 | protein_coding | protein_coding | ENST00000308330 | 13 | 78757 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.00123 | 125737 | 0 | 11 | 125748 | 0.0000437 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.260 | 485 | 469 | 1.03 | 0.0000240 | 5845 |
Missense in Polyphen | 149 | 188.44 | 0.79072 | 2349 | ||
Synonymous | -1.22 | 199 | 178 | 1.12 | 0.00000910 | 1848 |
Loss of Function | 5.25 | 5 | 41.5 | 0.120 | 0.00000227 | 489 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000185 | 0.000185 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000529 | 0.0000527 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Can function as a specific repressor of TGF-beta, activin, and BMP signaling through its interaction with the R-SMAD proteins. Antagonizes TGF-beta-induced cell proliferation arrest. {ECO:0000269|PubMed:15601644, ECO:0000269|PubMed:15647271}.;
- Pathway
- Clearance of Nuclear Envelope Membranes from Chromatin;Nuclear Envelope Breakdown;Mitotic Prophase;Initiation of Nuclear Envelope Reformation;Nuclear Envelope Reassembly;Mitotic Anaphase;Mitotic Metaphase and Anaphase;M Phase;Cell Cycle;Cell Cycle, Mitotic
(Consensus)
Recessive Scores
- pRec
- 0.161
Intolerance Scores
- loftool
- 0.440
- rvis_EVS
- -1.15
- rvis_percentile_EVS
- 6.23
Haploinsufficiency Scores
- pHI
- 0.487
- hipred
- Y
- hipred_score
- 0.816
- ghis
- 0.658
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.831
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lemd3
- Phenotype
- cellular phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- angiogenesis;nuclear envelope organization;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of BMP signaling pathway;negative regulation of activin receptor signaling pathway;regulation of intracellular signal transduction
- Cellular component
- nuclear inner membrane;integral component of nuclear inner membrane;membrane;integral component of membrane;nuclear membrane
- Molecular function
- DNA binding;protein binding